The “Mevalonate hypothesis”: a cholesterol-independent alternative for the etiology of atherosclerosis
<p>Abstract</p> <p>The “cholesterol hypothesis” is the leading theory to explain the cause of atherosclerosis. The “cholesterol hypothesis” assumes that plasma (LDL) cholesterol is an important causal factor for atherosclerosis.</p> <p>However, data of at least seven pl...
Main Author: | Keizer Hiskias G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/11/1/149 |
Similar Items
-
Cholesterol and Inflammation in Atherosclerosis: An Immune-Metabolic Hypothesis
by: Didac Mauricio, et al.
Published: (2020-08-01) -
HSF1 Regulates Mevalonate and Cholesterol Biosynthesis Pathways
by: Hyeji Kang, et al.
Published: (2019-09-01) -
Cholesterol and mevalonate metabolism: a time course study in vivo*
by: J.C. Elwood, et al.
Published: (1961-10-01) -
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
by: Kagiso Laka, et al.
Published: (2022-03-01) -
The effect of decreased plasma cholesterol concentration on circulatinga mevalonate metabolism in rats.
by: K R Feingold, et al.
Published: (1981-08-01)